Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 13, 2016 4:06 AM ET

Healthcare Providers and Services

Company Overview of Liberty Dialysis, LLC

Company Overview

Liberty Dialysis, LLC develops, owns, and operates dialysis clinics in the United States. It offers chronic kidney disease outreach programs for patients. The company was founded in 2002 and is based in Mercer Island, Washington. As of February 28, 2012, Liberty Dialysis, LLC operates as a subsidiary of Fresenius Medical Care AG & Co. KGAA.

7650 SE 27th Street

Suite 200

Mercer Island, WA 98040

United States

Founded in 2002

Phone:

206-236-5001

Fax:

206-236-5002

Key Executives for Liberty Dialysis, LLC

Co-Founder and Chief Executive Officer
Co Founder
Chief Financial Officer
Chief Operating Officer
Executive Vice President
Compensation as of Fiscal Year 2015.

Liberty Dialysis, LLC Key Developments

State of Hawaii Wins $7 Million Lawsuit against Liberty Dialysis, Sues for False Claims

Liberty Dialysis is being ordered to pay $7 million in overpayments to the state of Hawaii, which has filed a second false claims lawsuit against the dialysis provider. The $7 million reimbursement was awarded to the state to cover overpayments to the company between 2006 and 2010 for Liberty's Medicaid patients. A computer error in the state Department of Human Services claims processing system led to the original overpayments. The new lawsuit, filed alleges that Liberty knowingly exaggerated claims for a drug, despite an alert from a billing consultant. The lawsuit alleges reimbursement requests were inflated for a drug called Epogen, which is used during dialysis treatment. The complaint asserts intentional and negligent misrepresentation, unjust enrichment, and that a breach of contract took place. The state will seek triple damages for the overpayment plus civil penalties of $5,500 to $11,000 for each false claim submitted, as well as attorney fees and costs.

Similar Private Companies By Industry

Company Name Region
DLP Marquette General Hospital, LLC United States
Synarc-BioCore Holdings, LLC United States
Coventry Health Care Of Illinois, Inc United States
Nurses of Today, Inc United States
Allen Hospital Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Liberty Dialysis, LLC, please visit www.libertydialysis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.